verapamil and mirabegron

verapamil has been researched along with mirabegron in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ball, R; Berger, R; Di Salvo, J; Dingley, K; Edmondson, SD; Fitzmaurice, A; Frenkl, T; Gichuru, LN; Goble, SD; Green, S; Ha, S; Harper, B; Hurley, AL; Jochnowitz, N; Kar, NF; Levorse, D; Miller, RR; Mistry, S; Morriello, G; Moyes, CR; Nagabukuro, H; Ormes, J; Sacre-Salem, B; Salituro, GM; Sanfiz, A; Shen, DM; Stevenson, AS; Struthers, M; Villa, K; Wang, L; Weber, AE; Zamlynny, B; Zhu, C	1

Other Studies

1 other study(ies) available for verapamil and mirabegron

Article	Year
Discovery of Vibegron: A Potent and Selective β3 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder. Journal of medicinal chemistry, 2016, Jan-28, Volume: 59, Issue:2 Topics: Adrenergic beta-3 Receptor Agonists; Animals; CHO Cells; Cricetinae; Cricetulus; Drug Discovery; Female; Humans; Lipidoses; Microsomes, Liver; Models, Molecular; Pyrimidinones; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship; Urinary Bladder; Urinary Bladder, Overactive; Urination; X-Ray Diffraction	2016

Article

Year

Discovery of Vibegron: A Potent and Selective β3 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder.

Journal of medicinal chemistry, 2016, Jan-28, Volume: 59, Issue:2

Topics: Adrenergic beta-3 Receptor Agonists; Animals; CHO Cells; Cricetinae; Cricetulus; Drug Discovery; Female; Humans; Lipidoses; Microsomes, Liver; Models, Molecular; Pyrimidinones; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship; Urinary Bladder; Urinary Bladder, Overactive; Urination; X-Ray Diffraction

2016